MedPath

RLF-OD032

Generic Name
RLF-OD032

Study on Sapropterin Dihydrochloride Oral Suspension in Healthy Subjects

Phase 1
Completed
Conditions
Bioavailability
Interventions
First Posted Date
2024-07-01
Last Posted Date
2024-12-12
Lead Sponsor
APR Applied Pharma Research s.a.
Target Recruit Count
16
Registration Number
NCT06481709
Locations
🇨🇦

Pharma Medica Research Inc. 4770 Sheppard Ave E,, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath